Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

PRESS: Aetna, Humana Map Legal Strategy to Salvage Merger <i>(Reuters)</i>

PRESS: Aetna, Humana Map Legal Strategy to Salvage Merger (Reuters)

Related Content

Antitrust and Competition Life Sciences Year in Review 2025

Regulators Consider a New Theory on Algorithmic Coordination

DMA Review Moves Forward: Commission Publishes Consultation Feedback and Industry Positions

European Commission Publishes Final FSR Guidelines: Key Takeaways for M&A, Procurement, and Subsidy Control

2026 HSR Thresholds Announced: $133.9 million

Resale Price Fixing in Fashion: European Union Imposes $182 Million Fine on Gucci, Chloé, and Loewe (The Global Regulatory Developments Journal)

Goodwin Antitrust and Regulatory Shorts: EC Issues First Non-Compliance Fine Under the DSA: X Fined €120 Million for Dark Patterns and Transparency Failures

Antitrust Authorities Rethink Coordination for the Digital Age

The Future of Life Sciences Antitrust

Three Goodwin Partners Named 2026 Lawdragon Leading Global Antitrust & Competition Lawyers

Goodwin Releases 2025-26 Update to Annual Biosimilars Guide

Goodwin Named an Elite Firm for Antitrust Law in GCR 100 2026

Law Firms Ponder Lobbying DOJ, White House to Get Deals Through (Bloomberg Law)

Best Law Firms 2026 Names Goodwin ERISA Litigation Law Firm of the Year and Recognizes 50 Practice Areas

Goodwin Represents FountainVest in its Investment in SML Group

Benchmark Litigation US 2026 Recognize Partners and Practices Nationwide

Antitrust & Competition

Mergers & Acquisitions